Clal Biotechnology reported ILS11.67 in PE Price to Earnings for its fiscal quarter ending in December of 2022.





Pe Change Date
Clal Biotechnology ILS 11.67 2.62 Dec/2022
RedHill Biopharma USD 0.04 0.03 Jun/2025